Efficacy of Jiedu Tongluo Tiaogan Formula on Type 2 Diabetic Lower Extremity Arteriosclerosis Obliterans: Study Protocol for a Metabolomics-Based Randomized Controlled Clinical Trial

Tianjiao Liu, Chunli Piao, Yuting Peng, Jinghan Xu, Yue Qu, Qi Li, Xiaohua Zhao, Xuemin Wu, Pei Li, Yawen Fan
doi: https://doi.org/10.1101/2022.06.25.22276893

Article usage

Article usage: June 2022 to July 2025

AbstractFullPdf
Jun 2022169722
Jul 2022226428
Aug 2022232511
Sep 20228305
Oct 20226306
Nov 20225813
Dec 20222854
Jan 20232749
Feb 202328314
Mar 20232833
Apr 20232231
May 20231035
Jun 2023842
Jul 2023811
Aug 202322127
Sep 20231343
Oct 20231336
Nov 20231553
Dec 2023934
Jan 2024701
Feb 2024713
Mar 2024832
Apr 202412110
May 20241444
Jun 2024814
Jul 2024929
Aug 202411223
Sep 20242523
Oct 20241097
Nov 2024507
Dec 2024802
Jan 202511312
Feb 2025553414
Mar 2025212412
Apr 2025421615
May 2025161412
Jun 2025181114
Jul 2025145414
Back to top
Posted June 27, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Efficacy of Jiedu Tongluo Tiaogan Formula on Type 2 Diabetic Lower Extremity Arteriosclerosis Obliterans: Study Protocol for a Metabolomics-Based Randomized Controlled Clinical Trial
Tianjiao Liu, Chunli Piao, Yuting Peng, Jinghan Xu, Yue Qu, Qi Li, Xiaohua Zhao, Xuemin Wu, Pei Li, Yawen Fan
medRxiv 2022.06.25.22276893; doi: https://doi.org/10.1101/2022.06.25.22276893
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area